2017 Impact factor for Journal of Heart and Lung Transplantation on the rise -- again
ADDISON, TX – 28 June, 2018 – The 2017 impact factor for the Journal of Heart and Lung Transplantation rose again this year, standing at 7.955, up from last year’s 7.114.
In addition, the Journal continued to rank at #1 in transplantation and #3 out of 200 in the highly competitive field of surgery.
“We are thrilled to see the Journal growing in influence and
reach,” said Mandeep R. Mehra, MD, Editor in Chief, and the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital and Harvard Medical School. “This represents the
strength within the ISHLT community and beyond in expressing their scientific voice through the JHLT medium.”
The impact factor is published in the annual Journal Citation Reports (JCR). The calculation is determined by the number of 2017 citations accumulated for JHLT manuscripts published in the previous two years.
In addition, the Journal’s 2017 Cite Score also grew considerably from 4.6 to 5.32. The Journal’s Cite Score rankings now stand at #1 in transplant, #2 in surgery, #2 in respiratory and #9 in the cardiovascular categories.
The Cite Score, which is updated monthly, evaluates all published articles in a journal over a three-year period. In addition, it includes editorials and letters, which the Impact score does not. Cite Score is a newer metric and launched in 2016.
More on Impact factor
In the field of surgery, only the more general Annals of Surgery and JAMA Surgery ranked higher than JHLT. Thus, the JHLT is the highest-ranking subspecialty focused surgical journal worldwide.
In the substantially competitive cardiovascular field, JHLT ranked twelfth out of 128.
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.